Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Case Reports in Obstetrics and Gynecology|November 4, 2022
An Extragastrointestinal Tumor Diagnosed as a Vaginal Mass during PregnancyReo Ando, Shuichi Taniguchi, Shuji Arita, et al.Case Reports in Oncology|February 17, 2017
Primary Ewing's Sarcoma of the Sinonasal Tract: A Case ReportTomoharu Suzuki, Ryuji Yasumatsu, Torahiko Nakashima, et al.Anticancer Research|October 25, 2017
Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal CancerTatsuhiro Kajitani, Akitaka Makiyama, Shuji Arita, et al.Medical Oncology (Northwood, London, England)|September 13, 2007
Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary siteHitoshi Kusaba, Yoshihiro Shibata, Shuji Arita, et al.Internal Medicine (Tokyo, Japan)|June 26, 2025
Pneumocystis pneumonia in a patient receiving nab-paclitaxel plus gemcitabine for unresectable pancreatic cancer: A case reportTakano Akihisa, Daisuke Himeji, Ritsuya Shiiba, et al.Oncology Letters|September 12, 2012
Irinotecan-based combination chemotherapy for metastatic small intestinal adenocarcinomaYoshihiro Shibata, Eishi Baba, Hiroshi Ariyama, et al.Anti-Cancer Drugs|March 22, 2006
In-vitro differential metabolism and activity of 5-fluorouracil between short-term, high-dose and long-term, low-dose treatments in human squamous carcinoma cellsBaoli Qin, Risa Tanaka, Hiroshi Ariyama, et al.Anti-Cancer Drugs|March 22, 2006
In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell linesBaoli Qin, Risa Tanaka, Yoshihiro Shibata, et al.Cancer Chemotherapy and Pharmacology|December 12, 2012
Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancerHitoshi Kusaba, Taito Esaki, Junji Kishimoto, et al.European Journal of Immunology|April 22, 2008
B cell activation regulates exosomal HLA productionShuji Arita, Eishi Baba, Yoshihiro Shibata, et al.Pageof 6